GE Healthcare and Insightec announced FDA approval and CE mark for Exablate Neuro compatible with the Signa Premier MRI system.
- Exablate Neuro is a focused ultrasound platform for treating deep in the brain with no surgical incisions
- Exablate Neuro has FDA approval for the treatment of medication-refractory essential tremor and tremor-dominant Parkinson’s disease and CE mark for the treatment of Essential Tremor, Tremor Dominant Parkinson’s Disease-Unilateral and neuropathic pain
Link to Statement: INSIGHTEC Receives FDA Approval and CE Mark for Exablate Neuro With GE SIGNA Premier MR System
©2019 Bloomberg L.P. All rights reserved. Used with permission
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.
